Tekla Healthcare Investor... (HQH)

AI Score

Unlock

15.07

-0.04 (-0.26%)

At close: Apr 17, 2025, 3:59 PM

15.34

1.82%

After-hours: Apr 17, 2025, 05:16 PM EDT

Tekla Healthcare Investors Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	10.77M	9.97M	10.29M	9.94M	8.27M	7.17M	6.48M	7.18M	8.93M	8.91M	7.6M	7.5M	6.78M	5.79M	5.62M	5.29M	4.8M	5.06M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	10.77M	9.97M	10.29M	9.94M	8.27M	7.17M	6.48M	7.18M	8.93M	8.91M	7.6M	7.5M	6.78M	5.79M	5.62M	5.29M	4.8M	5.06M
Operating Income	-220.27K	-1.05M	-1.19M	-1.6M	-3.67M	-5.57M	-6.23M	-4.67M	-1.97M	-1.46M	-2.87M	-3.28M	-4.12M	-5.25M	-5.16M	-5.18M	-6.28M	-7.17M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	184.95M	72.87M	56.33M	3.98M	-194.23M	-48.44M	155.18M	281.74M	241.2M	-12.87M	-145.29M	50.32M	69.2M	20.07M	121.28M	98.19M	-56.02M	-227.47M
Net Income	184.95M	72.87M	56.33M	3.98M	-194.23M	-48.44M	155.18M	281.74M	241.2M	-12.87M	-145.29M	50.32M	69.2M	20.07M	121.28M	98.19M	-56.02M	-227.47M
Selling & General & Admin	10.99M	11.02M	11.48M	11.54M	11.94M	12.74M	12.71M	11.84M	10.9M	10.37M	10.47M	10.78M	10.9M	11.05M	10.78M	10.47M	11.08M	12.23M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	10.99M	11.02M	11.48M	11.54M	11.94M	12.74M	12.71M	11.84M	10.9M	10.37M	10.47M	10.78M	10.9M	11.05M	10.78M	10.47M	11.08M	12.23M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	56.39K	18.63K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	10.99M	11.02M	11.48M	11.54M	11.94M	12.74M	12.71M	11.84M	10.9M	10.37M	10.47M	10.78M	10.9M	11.05M	10.78M	10.47M	11.08M	12.23M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	53.63M	50.62M	50.53M	48.35M	48.34M	46.34M	46.2M	44.65M	44.66M	43.08M	43.31M	42.34M	42.88M	41.55M	41.44M	39.86M	39.81M	38.19M
Shares Outstanding (Diluted)	53.63M	50.62M	50.53M	48.35M	48.34M	46.34M	46.2M	44.65M	44.66M	43.08M	43.31M	42.34M	42.88M	41.55M	41.44M	39.86M	39.81M	38.19M
EPS (Basic)	3.56	1.44	1.19	0.08	-4.12	-1.04	3.42	6.31	5.44	-0.3	-3.4	1.15	1.56	0.48	2.96	2.47	-1.53	-5.96
EPS (Diluted)	3.56	1.44	1.19	0.08	-4.12	-1.04	3.42	6.31	5.44	-0.3	-3.4	1.15	1.56	0.48	2.96	2.47	-1.53	-5.96
EBITDA	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBIT	-220.27K	-1.05M	-1.19M	-1.6M	-3.67M	-5.57M	-6.23M	-4.67M	-1.97M	-1.46M	-2.87M	-3.28M	-4.12M	-5.25M	-5.16M	-5.18M	-6.28M	-7.17M
Depreciation & Amortization	220.27K	1.05M	1.19M	1.6M	3.67M	5.57M	6.23M	4.67M	1.97M	1.46M	2.87M	3.28M	4.12M	5.25M	5.16M	5.18M	6.28M	7.17M